Evaluation of penile hemodynamic status and adjustment of treatment alternatives in Peyronie's disease.
OBJECTIVE
Erectile dysfunction may be observed in up to 80% of patients with Peyronie's disease. An objective evaluation of the erectile function is attempted to work out in patients with Peyronie's disease.


METHODS
Penile deformity, sexual function and penile vascular status were analyzed in 123 patients with Peyronie's disease, who had not received any pertinent treatment.


RESULTS
Penile deformity, palpable plaque and pain on erection were seen in 112 (91%), 97 (78.8%) and 27 (21.9%) of the 123 patients, respectively. Of the 76 patients evaluated by color Doppler ultrasounography, veno-occlusive dysfunction as the vascular component for erectile dysfunction was found in 17 (22.3%), arterial insufficiency in 10 (13.1%) and a mixed picture in 23 (30.2%).


CONCLUSIONS
The documentation of penile erectile function and the determination of the vascular status using color Doppler ultrasonography can guide the appropriate therapeutic choice.
D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010411:Penile Induration / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology*; D010413:Penis / Q000098:blood supply* / Q000473:pathology / Q000503:physiopathology; D018615:Ultrasonography, Doppler, Color; D014810:Vitamin E / Q000627:therapeutic use
D000975:Antioxidants; D006074:Gout Suppressants; D014810:Vitamin E; D003078:Colchicine